Humana (HUM)
(Delayed Data from NYSE)
$305.90 USD
-5.51 (-1.77%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $306.06 +0.16 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HUM 305.90 -5.51(-1.77%)
Will HUM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HUM
Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked
Molina Healthcare (MOH) Q1 Earnings Beat on Growing Membership
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Humana (HUM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for HUM
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Buy Rating Affirmed for Humana Despite Earnings Forecast Adjustment: Growth and Fundamentals Remain Strong
Humana’s Strong Q1 Performance and Cost Efficiency Bolster Buy Rating Despite 2025 Uncertainties
TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
Humana Healthy Horizons Commits $500K to Improve Health of Louisianians